Remove Biotech Remove Data Remove Machine Learning
article thumbnail

Stability AI backs effort to bring machine learning to biomed

TechCrunch

Stability AI , the venture-backed startup behind the text-to-image AI system Stable Diffusion, is funding a wide-ranging effort to apply AI to the frontiers of biotech. Called OpenBioML , the endeavor’s first projects will focus on machine learning-based approaches to DNA sequencing, protein folding and computational biochemistry.

article thumbnail

Cellino is using AI and machine learning to scale production of stem cell therapies

TechCrunch

technology, machine learning, hardware, software — and yes, lasers! Founded by a team whose backgrounds include physics, stem cell biology, and machine learning, Cellino operates in the regenerative medicine industry. — could eventually democratize access to cell therapies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Qventus Latest Healthcare AI Startup To Raise Big

Crunchbase News

Qventus platform tries to address operational inefficiencies in both inpatient and outpatient settings using generative AI, machine learning and behavioural science. Related reading: The Weeks Biggest Funding Rounds: Data Storage And Lots Of Biotech Illustration: Dom Guzman The round was led by Kleiner Perkins.

article thumbnail

TechCrunch+ roundup: New VC rules, AI biotech investor survey, Instagram ad case study

TechCrunch

” In a data-driven piece that looks at post-money valuations, deal sizes and dilution rates going back to 2012, Mitchem says we’re now heading into a new era where the tech industry will embrace “growth at reasonable costs.” 6 investors discuss why AI is more than just a buzzword in biotech.

article thumbnail

Avalo uses machine learning to accelerate the adaptation of crops to climate change

TechCrunch

In an increasingly hot biotech market, protecting IP is key. In that same body of data relating to cold-tolerant rice, “We found 32 genes of interest, and based on our simulations and retrospective studies, we know that all of those are truly causal. The Avalo model clears up the data and selects only the most promising ones.

article thumbnail

Biotech Boom: Executive Search Strategies in Life Sciences

N2Growth Blog

Understanding the Unique Challenges in Recruiting for Biotech and Life Sciences The recruitment process in the biotech and life sciences industry comes with its own set of unique challenges. One of the primary obstacles is the need for more highly skilled and qualified talent.

Biotech 178
article thumbnail

Immunai raises $60M as it expands from improving immune therapies to discovering new ones, too

TechCrunch

Just three years after its founding, biotech startup Immunai has raised $60 million in Series A funding, bringing its total raised to over $80 million. “I hope it doesn’t sound corny, but we don’t have the luxury to move more slowly,” explained Immunai co-founder and CEO Noam Solomon in an interview.